The copper/caeruloplasmin ratio in routine clinical practice in different laboratories

Journal of Clinical Pathology

Volumn 62, Issue 1, 2009, Pages 60-63

  Twomey, P J ^a   Wierzbicki, A S ^b   Reynolds, T M ^c   Viljoen, A ^d  

^a IPSWICH HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c QUEEN S HOSPITAL   (United Kingdom)

^d LISTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER;

ARTICLE; CLINICAL PRACTICE; LABORATORY; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

CERULOPLASMIN; COPPER; HUMANS; LABORATORIES, HOSPITAL; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES;

EID: 58349101957     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2007.055111     Document Type: Article

References (23)

1. Uauy R, Olivares M, Gonzalez M. Essentiality of copper in humans. Am J Clin Nutr 1998;67:952S-9S.
2. Turnlund JR. Copper. In: Shils M, Olson JA, Shike M, et al., eds Nutrition in health and disease. 9th edn. Baltimore: Williams & Wilkins, 1999:241-52.
3. Harris ED. Copper. In: O'Dell BL, Sunde RA, eds. Handbook of nutritionally essential minerals. New York: Marcel Dekker, Inc, 1997:231-73.
4. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press, 2001:224-57.
5. Huff JD, Keung YK, Thakuri M, et al. Copper deficiency causes reversible myelodysplasia. Am J Hematol 2007;82:625-30.
6. Gaffney D, Fell GS, St J O'Reilly D. Wilson's disease: acute and presymptomatic laboratory diagnosis and monitoring. J Clin Pathol 2000;53:807-12.
7. Langner C, Denk H. Wilson Disease. Virchows Arch 2004;445:111-18.
8. Roelofsen H, Van Luyn MJ, Miura N, et al. Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion. Gastroenterology 2000;119:782-93.
9. Ferenci P, Czlonkowska A, Merle U, et al. Late-onset Wilson's disease. Gastroenterology 2007;132:1294-8.
10. Steindl P, Ferenci P, Dienes HP, et al. Wilson's disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology 1997;113:212-18.
11. Gitlin N. Wilson's disease: the scourge of copper. J Hepatol 1998;28:734-9.
12. Milne DB. Trace elements. In: Burtis CA, Ashwood ER, eds. Tietz textbook of clinical chemistry. 3rd edn. Philadelphia: WB Saunders Co.
13. Gibbs K, Walshe JM. A study of caeruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups. O J Med 1979;48:447-63.
14. Walshe JM. Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically. Ann Clin Biochem 2003;40:115- 21.
15. Twomey PJ, Viljoen A, House IM, et al. Problems with non-ceruloplasmin bound copper ('free copper' or copper index). Clin Chem 2005;51:1558-9.
16. Twomey PJ, Reynolds TM, Wierzbicki AS, et al. The relationship between serum copper and ceruloplasmin in routine clinical practice. Int J Clin Pract 2008;62:485-7.
17. Twomey PJ, Viljoen A, House IM, et al. Copperxaeruloplasmin ratio. J Clin Pathol 2007;60:441-2.
18. Jones R, Payne B. Clinical investigation and statistics in laboratory medicine. London: ACB Venture Publications, 1997.
19. Beetham R, White P, Riches P, et al. Use of CRM 470/RPPHS has not achieved true consensus for ceruloplasmin measurement. Clin Chem 2002;48:2293-4.
20. Viljoen A, Twomey PJ. Limitations of transferability of absolute cut-points in nonstandardised assays. J Clin Pathol 2007:60:584.
21. Holmberg CG, Laurell CB. Investigations in serum copper. II. Isolation of the coppercontaining protein and the description of some of its properties. Acta Chem Scand 1948;2:550-6.
22. Johnson Am. Other proteins: caeruloplasmin. In Ritchie RF, Navolotskaia 0, eds. Serum proteins in clinical medicine. 1st edn. Scarborough, ME: Foundation for Blood Research, 1996.
23. Bielli P, Calabrese L. Structure to function relationships in ceruloplasmin: a 'moonlighting' protein. Cell Mol Life Sci 2002;59:1413-27.